Patents by Inventor Scott J. Dylla

Scott J. Dylla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-DLL3 antibody drug conjugates
    Patent number: 9770518
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: September 26, 2017
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20170266312
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • METHODS OF DELIVERING DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20170266313
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER
    Publication number: 20170266315
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • METHODS OF MAKING DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20170266314
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • Modulators and methods of use
    Patent number: 9765136
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: September 19, 2017
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Johannes Hampl, Scott J. Dylla, Orit Foord, Robert A. Stull
  • Methods of making DLL3 antibody drug conjugates
    Patent number: 9764042
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: September 19, 2017
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti SEZ6 antibodies and methods of use
    Patent number: 9676850
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: June 13, 2017
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Laura Saunders, Scott J. Dylla, Orit Foord, Robert A. Stull, Michael Torgov, Hui Shao, David Liu
  • ANTI-CD324 MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20170121416
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 4, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. STULL, Monette AUJAY, Orit FOORD, Alex BANKOVICH, Johannes HAMPL, Scott J. DYLLA, David LIU
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20170081419
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: August 29, 2016
    Publication date: March 23, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: Scott J. Dylla, Orit Foord, Robert A. Stull, Wade C. Anderson, Saiyou Ohshima
  • ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES
    Publication number: 20170072066
    Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: June 8, 2016
    Publication date: March 16, 2017
    Applicants: PFIZER, INC., STEMCENTRX, INC.
    Inventors: Marc Isaac DAMELIN, Kiran Manohar KHANDKE, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • NOVEL ANTI-RNF43 ANTIBODIES AND METHODS OF USE
    Publication number: 20170073430
    Abstract: The invention discloses novel anti-RNF43 antibodies and derivatives thereof, including antibody drug conjugates, and methods of using such anti-RNF43 antibodies and antibody drug conjugates to diagnose and treat cancer.
    Type: Application
    Filed: April 21, 2015
    Publication date: March 16, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: MANDY BOONTANRART, DEEPTI ROKKAM, DAVID LIU, SCOTT J. DYLLA, MONETTE AUJAY
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20170000901
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: September 15, 2016
    Publication date: January 5, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: Robert A. STULL, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • Anti-CD324 monoclonal antibodies and uses thereof
    Patent number: 9534058
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: January 3, 2017
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Monette Aujay, Orit Foord, Alex Bankovich, Johannes Hampl, Scott J. Dylla, David Liu
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9486537
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: November 8, 2016
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9480757
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: November 1, 2016
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9481727
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: November 1, 2016
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Modulators and methods of use
    Patent number: 9458231
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: October 4, 2016
    Assignee: Stemcentrx, Inc.
    Inventors: Scott J. Dylla, Orit Foord, Robert A. Stull, Wade C. Anderson, Saiyou Ohshima
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20160272723
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: March 30, 2016
    Publication date: September 22, 2016
    Applicant: STEMCENTRX, INC.
    Inventors: ORIT FOORD, SCOTT J. DYLLA, ROBERT A. STULL, ALEX BANKOVICH, ALEXANDRA LEIDA LIANA LAZETIC, JEFFREY BERNSTEIN
  • NOVEL MODULATORS AND METHODS OF USE
    Publication number: 20160264653
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: March 17, 2016
    Publication date: September 15, 2016
    Applicant: STEMCENTRX, INC.
    Inventors: JOHANNES HAMPL, SCOTT J. DYLLA, ORIT FOORD, ROBERT A. STULL